Connecting Regions of Asia.

China Rushes COVID-19 Vaccination Programme To Public Despite Safety Fears


China plans to start opening its COVID-19 vaccination programme to members of the public in southwestern Sichuan province early next year, health officials said, despite the inoculations not yet receiving official approval.
At least one million people have already received a jab in China after vaccine candidates were approved for “emergency use”, but so far they have been limited to priority groups such as state employees and international students.
China has five coronavirus vaccines in the final stages of development — but none has received official approval from authorities and the results of late-stage trials have yet to be published.
On an international level, various vaccine manufacturers are rushing to produce a COVID-19 vaccine, despite warnings from a growing number of health professionals about the potential dangers of a rushed and largely untested product and its efficacy.
Vaccine safety is a subject largely censored by the pharmaceutical industry and the media, despite growing calls from a small but growing group of doctors over the potential dangers from side effects.
A Chinese provincial health official told local media that vaccines will be provided to the general public in Sichuan after the Lunar New year holidays in February.
Officials said Thursday that 118,000 vaccine doses had arrived in the province so far, with plans to inoculate all high-risk groups by February 5 before rolling out the programme to the rest of the population.
They did not specify who developed the vaccines.
Sichuan is the first province to outline a timeline of its vaccination plans for the general public.
The coronavirus – which first emerged in China late last year – has largely been brought under control in the country, but there have been a series of domestic outbreaks.
Sichuan has been hit by a small cluster of Covid-19 cases in recent weeks, with one more virus infection reported Friday.

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More